Collectively, three dysregulated lipid metabolism processes, namely increased lipogenic capacity, decreased lipid catabolism, and elevated cholesterol synthesis, are all likely to contribute to the accumulation of fat in the liver, which is followed by a rapid progression from NAFLD to NASH when there is Cisd2 haploinsufficiency. This evidence concerns the gene CISD2 and metabolic dysfunction-associated steatotic liver disease.